(Total Views: 108)
Posted On: 02/14/2018 6:39:33 PM
Post# of 2022
NetworkNewsBreaks – EVIO, Inc. (EVIO) Adds New Executives to Management Team; Reports Q1 2018 Financial Results
EVIO (OTCQB: EVIO), a life sciences company and leading provider of quality control testing and advisory services to the regulated cannabis industry, has recently grown its top-tier management team by two former executives of Pfizer and Quest Diagnostics. The company’s recently appointed president Al Lustig fills the role of driving EVIO’s growth in new and current markets through sales and operational strategies. As the recently appointed Vice President of Operations, Ron Russak will focus on scaling existing and new laboratory operations to increase growth and profitability. Additionally, EVIO this morning announced financial and operating results for the first quarter of 2018 ended December 31, 2017. Among other highlights, first quarter revenue was $946,865, up 41.6% from the same period of the previous year. Gross profit showed a 168% increase over the first quarter of last year, totaling $210,602 for the first quarter 2018. “We are pleased with our first quarter results, especially with the year over year increase in activity in Oregon. The company is continuing to focus on laying a strong foundation to build upon,” EVIO chairman and CEO William Waldrop stated in the news release.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
EVIO (OTCQB: EVIO), a life sciences company and leading provider of quality control testing and advisory services to the regulated cannabis industry, has recently grown its top-tier management team by two former executives of Pfizer and Quest Diagnostics. The company’s recently appointed president Al Lustig fills the role of driving EVIO’s growth in new and current markets through sales and operational strategies. As the recently appointed Vice President of Operations, Ron Russak will focus on scaling existing and new laboratory operations to increase growth and profitability. Additionally, EVIO this morning announced financial and operating results for the first quarter of 2018 ended December 31, 2017. Among other highlights, first quarter revenue was $946,865, up 41.6% from the same period of the previous year. Gross profit showed a 168% increase over the first quarter of last year, totaling $210,602 for the first quarter 2018. “We are pleased with our first quarter results, especially with the year over year increase in activity in Oregon. The company is continuing to focus on laying a strong foundation to build upon,” EVIO chairman and CEO William Waldrop stated in the news release.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Scroll down for more posts ▼
